Priapism is a frequent and serious cause of morbidity in males with si
ckle cell disease. Acute priapism (AP) is preceeded in two-thirds of t
he cases by repeated minor events called stuttering priapism (SP). Sin
ce 1994, we have used a specific approach to prevent the commonly deva
sting effects of AP, using the alpha adrenergic agent etilefrine. Trea
tment of AP has been simplified (drainage without aspiration followed
by one or two intracavernous injections (ICI) of 10 mg of etilefrine,
until detumescence). For SP lasting more than one hour or causing pain
, we use oral etilefrine and/or self ICI. This strategy was effective
in five patients seen having AP, 21 patients with SP; it is simple, ch
eap, and avoids surgical procedure and transfusion. Morever, erectile
dysfunction, present in three patients, has been treated safely by ICI
of protaglandins.